While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Freenome, a biotechnology company pioneering an early cancer detection platform, today announced the publication of detailed results from the pivotal PREEMPT CRC study in JAMA.1 The publication ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

Human organs could be bioprinted within 10 years, according to a biotech startup. But first, the company plans to regenerate ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

Readers respond to an article about gene editing and object to cuts in research funding. Also: The Covid vaccine; Senator ...

Three-quarters of US-based researchers and graduate students are considering working abroad, according to a recent study.